Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway

Su-Lim Kim1, Hack Sun Choi1,2,3, Ji-Hyang Kim1

  • 1Department of Biotechnology, College of Applied Life Science, Jeju National University, Jeju, Republic of Korea.

Insights

Dihydrotanshinone (DHTS) effectively inhibits cancer stem cell (CSC) formation and breast tumor growth. DHTS targets the ROS/Stat3/IL-6 pathway, offering a potential therapeutic strategy against CSCs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer stem cells (CSCs) drive tumor metastasis and recurrence, representing critical therapeutic targets.
  • Identifying novel agents that selectively target CSCs is crucial for improving cancer treatment outcomes.

Purpose of the Study:

  • To investigate the efficacy of dihydrotanshinone (DHTS) in inhibiting cancer stem cell formation and identify its underlying molecular mechanisms.
  • To evaluate DHTS as a potential therapeutic agent against breast CSCs.

Main Methods:

  • Assessed DHTS effects on mammosphere formation and xenograft tumor growth.
  • Quantified CSC populations (CD44high/CD24low, ALDH-expressing) and self-renewal genes (Nanog, SOX2, OCT4, C-Myc, CD44).
  • Investigated DHTS-induced NOX5 activation, calcium influx, reactive oxygen species (ROS) production, Stat3 phosphorylation, and IL-6 secretion.

Main Results:

  • DHTS demonstrated dose-dependent inhibition of mammosphere formation and significant tumor growth reduction in vivo.
  • DHTS decreased CSC populations and downregulated key self-renewal genes.
  • DHTS activated NOX5, leading to increased ROS production, which subsequently reduced Stat3 phosphorylation and IL-6 secretion, thereby disrupting the CSC self-renewal pathway.

Conclusions:

  • DHTS inhibits CSC formation by inducing ROS production via NOX5 activation, leading to the deregulation of the Stat3/IL-6 signaling pathway.
  • These findings highlight DHTS as a promising therapeutic agent for targeting breast CSCs and overcoming treatment resistance.

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.3K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.8K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.9K